Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3163523 | Oral and Maxillofacial Surgery Clinics of North America | 2007 | 17 Pages |
Abstract
Preclinical studies have shown that rhBMP-2 induces normal physiologic bone in clinically relevant defects in the craniofacial skeleton. The newly formed bone assumes characteristics of the adjacent resident bone and allows placement, osseointegration/re-osseointegration, and functional loading of endosseous implants. Clinical studies optimizing dose, delivery technologies, and conditions for stimulation of bone growth will bring about a new era in dentistry. The ability to predictably promote osteogenesis through the use of bone morphogenetic protein technologies is not far from becoming a clinical reality and will have an astounding effect on how dentistry is practiced.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Ulf M.E. Wikesjö, Yi-Hao Huang, Giuseppe Polimeni, Mohammed Qahash,